Modified Aminoglycosides Bind Nucleic Acids in High-Molecular-Weight Complexes.

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Biochemistry

Background:

• Aminoglycosides are antibiotics targeting bacterial ribosomes.
• Research involved studying 6"-substituted tobramycin variants.

Purpose of the Study:

• To investigate the effects of novel aminoglycoside derivatives.
• To explore their potential as inhibitors of reverse transcription.
• To understand their interaction with nucleic acids.

Main Methods:

• Synthesis and testing of C12 and C14 linear alkyl substituted tobramycin variants.
• In vitro inhibition assays for reverse transcription.
• Nucleic acid binding affinity studies (DNA and RNA, single/double-stranded).

Main Results:

• Compounds with C12 or C14 linear alkyl substituents potently inhibit reverse transcription in vitro.
• These derivatives exhibit high-affinity binding to both DNA and RNA.
• Stable, high-molecular-weight complexes form between the compounds and nucleic acids.
• Amphiphilic nature suggests micelle/vesicle formation with bound nucleic acids.

Conclusions:

• The studied aminoglycoside derivatives are potent inhibitors of reverse transcription.
• They interact with nucleic acids, forming stable complexes.
• Potential applications include nucleic acid surface localization and cellular/organelle delivery systems.